Here’s what we’ll cover in this blog post:

Where most people go wrong when starting a longevity plan
Why a baseline assessment is the most important first step
The four core categories of testing you need in 2026
How to choose the right longevity focus based on your risk profile
A simple 3-layer plan for building a personalized, sustainable approach

Where Should You Start a Long-Term Longevity Plan?

Most people jump in at the wrong place.

They start with an unvetted supplement stack or a complex protocol they can’t sustain.

The right starting point is much more boring, but much more powerful.

1. Know your baseline

Before you start “doing more,” you need to understand your current healthspan risk profile. Which organs are aging faster than others, or which areas of health need your attention? Where is inflammation showing up?

In 2026, a good baseline should include four major domains:

Metabolic health: Fasting glucose, HbA1c, fasting insulin or HOMA-IR, lipids (apoB, LDL-C, HDL, triglycerides), and waist circumference or visceral fat estimate.

Inflammation & immune tone: hs-CRP (or CRP if that’s all you can get), cell blood count differentials, and autoimmune blood panels (if you have symptoms or family history).

Organ function: Kidney (creatinine, eGFR), liver (ALT, AST, GGT), cardio (blood pressure, resting heart rate, VO2-max estimates from wearables), muscle and bone mass (DXA if you’re at risk or over ~40–45, especially for women).

Biological age & function: At least one phenotypic/clinical biomarker-based age (e.g., PhenoAge-type calculators), ideally paired with functional health measures such as grip strength, walking speed, balance, and cognitive tests. Organ age assessments can help map which systems are “older” than others and identify vulnerabilities before clinical diagnosis.

You don’t need the fanciest test in the world. But you do need a clear snapshot of metabolism, inflammation, organ function, and functional capacity. From there, your goal over the next 12 months is simple: improve the trend line.

2. Pick your “anchor” domains

You can’t fix everything at once. The literature from 2025 makes it clear that some domains are more leveraged than others:

Metabolic health interventions include GLP-1, metformin, SGLT2i, exercise, and weight loss strategies.

Inflammation & immune dysregulation can be addressed with rapamycin, LDN, microdose GLP-1, vaccines, and stress management.

Mitochondria and muscle benefit from resistance training, high-quality protein, NAD+, Sermorelin, and rapamycin in the right dose/context.

Brain & cognitive function are supported by exercise, sleep, microdosing GLP-1, Methylene Blue, cognitive function assessments, vitamin B12, tadalafil, and NAD+ nasal spray.

Pick 1–2 primary domains to focus on first, guided by your baseline.

Example: If you have central obesity, high apoB, and high CRP, start with metabolic health and inflammation. If you’re thin, weak, low energy, and experience poor recovery, focus on mitochondria and muscle. If you have a strong family history of dementia, prioritize brain and vascular aging.

3. Commit to a 3-layer plan

A realistic longevity framework for 2026 includes:

Foundations (everyone, always): Sleep regularity, daily movement and weekly resistance training, a nutrient-dense, low ultra-processed food pattern, morning light exposure, stress management, and social connection.

Targeted therapeutics (based on risk + biomarkers): Personalized GLP-1s for metabolic and cardiometabolic disease risk, microdosing GLP-1 or LDN for inflammatory profiles, rapamycin for general longevity, NAD+ for energy, and tadalafil for vascular issues.

Cutting edge (track the future of longevity): Partial cellular reprogramming strategies, gene therapies for neurodegenerative or monogenic disease, therapeutic plasma exchange (TPE), aging vaccines, senolytics, and combination geroprotectors.

Your 2026 plan is not about doing everything. It’s about knowing where you are, choosing the right starting levers, and creating a feedback loop.